Rebecca A. Campbell, Andrew M Wood, Patrick Michael, David Shin, Nikhil Pramod, Samuel C. Haywood, M. Eltemamy, Christopher J. Weight, Georges-Pascal Haber, Jesse McKenney, Jane Nyugen, Sean Williamson, Christopher Przybycin, Reza Alaghehbandan, N. Almassi
{"title":"对非肌层浸润性膀胱癌患者进行病理复查的重要性 - 评估分级、临床分期和风险分层的变化","authors":"Rebecca A. Campbell, Andrew M Wood, Patrick Michael, David Shin, Nikhil Pramod, Samuel C. Haywood, M. Eltemamy, Christopher J. Weight, Georges-Pascal Haber, Jesse McKenney, Jane Nyugen, Sean Williamson, Christopher Przybycin, Reza Alaghehbandan, N. Almassi","doi":"10.1016/j.urolonc.2024.01.167","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":506909,"journal":{"name":"Urologic Oncology: Seminars and Original Investigations","volume":"92 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IMPORTANCE OF PATHOLOGIC RE-REVIEW FOR PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER – EVALUATING CHANGE IN GRADE, CLINICAL T STAGE AND RISK STRATIFICATION\",\"authors\":\"Rebecca A. Campbell, Andrew M Wood, Patrick Michael, David Shin, Nikhil Pramod, Samuel C. Haywood, M. Eltemamy, Christopher J. Weight, Georges-Pascal Haber, Jesse McKenney, Jane Nyugen, Sean Williamson, Christopher Przybycin, Reza Alaghehbandan, N. Almassi\",\"doi\":\"10.1016/j.urolonc.2024.01.167\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":506909,\"journal\":{\"name\":\"Urologic Oncology: Seminars and Original Investigations\",\"volume\":\"92 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urologic Oncology: Seminars and Original Investigations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.urolonc.2024.01.167\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology: Seminars and Original Investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2024.01.167","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IMPORTANCE OF PATHOLOGIC RE-REVIEW FOR PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER – EVALUATING CHANGE IN GRADE, CLINICAL T STAGE AND RISK STRATIFICATION